Tatva Chintan Pharma
Ticker >

Tatva Chintan Pharma share price

Tatva Chintan Pharma Chem Ltd.

NSE: TATVA BSE: 543321 SECTOR: Chemicals  130k   464   84

1216.60
-28.95 (-2.32%)
BSE: 06 May 04:01 PM

Price Summary

Today's High

₹ 1280

Today's Low

₹ 1209.6

52 Week High

₹ 1888.05

52 Week Low

₹ 1063.35

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2845.88 Cr.

Enterprise Value

₹ 2977.55 Cr.

No. of Shares

2.34 Cr.

P/E

96.97

P/B

3.92

Face Value

₹ 10

Div. Yield

0.16 %

Book Value (TTM)

₹  310.31

CASH

₹ 38.58 Cr.

DEBT

₹ 170.26 Cr.

Promoter Holding

72.02 %

EPS (TTM)

₹  12.55

Sales Growth

-5.79%

ROE

8.31 %

ROCE

7.49%

Profit Growth

-57.84 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-5.79%
3 Year16.66%
5 Year25.51%

Profit Growth

1 Year-57.84%
3 Year4.99%
5 Year27.71%

ROE%

1 Year8.31%
3 Year25.3%
5 Year28.14%

ROCE %

1 Year7.49%
3 Year20.39%
5 Year22.03%

Debt/Equity

0.3373

Price to Cash Flow

119.93

Interest Cover Ratio

5.55655949307674

CFO/PAT (5 Yr. Avg.)

0.390586927889365

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 72.02 0
Dec 2023 72.02 0
Sep 2023 72.02 0
Jun 2023 79.17 0
Mar 2023 79.17 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 16.662038495101% for the Past 3 years.
  • Company has been maintaining healthy ROE of 25.3031965052375% over the past 3 years.
  • Company has been maintaining healthy ROCE of 20.3898800131309% over the past 3 years.
  • The company has a high promoter holding of 72.02%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.45656485351344.

 Limitations

  • The company has shown a poor profit growth of 4.99217957543334% for the Past 3 years.
  • Tax rate is low at -4.20797816177796.
  • The company is trading at a high PE of 96.97.
  • The company is trading at a high EV/EBITDA of 37.9597.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 119.41 106.11 92.57 86.07 93.93
Total Expenditure 104 86.49 71.83 73.76 79.73
Operating Profit 15.4 19.61 20.74 12.31 14.2
Other Income 0.78 1.02 0.76 1.21 4.53
Interest 3.18 2.9 3.01 0.38 0.22
Depreciation 2.53 6.01 6.78 6.58 6.23
Exceptional Items -3.59 0 0 0 0
Profit Before Tax 6.89 11.72 11.71 6.56 12.28
Tax -9.26 3.47 3.5 1.91 4.03
Profit After Tax 16.15 8.25 8.2 4.65 8.25
Adjusted EPS (Rs) 7.29 3.72 3.51 1.99 3.53

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 202.9 253.84 291.19 427.81 403.04
Total Expenditure 169.71 201.14 225.8 321.81 348.23
Operating Profit 33.19 52.7 65.39 106.01 54.82
Other Income 0.44 0.56 5.1 10.63 5.68
Interest 3.94 4.25 4.41 5.19 8.52
Depreciation 4.02 4.79 6.73 8.18 9.55
Exceptional Items 0.75 0 0 0 -3.59
Profit Before Tax 26.43 44.22 59.35 103.27 38.83
Tax 6.24 9.25 7.99 7.28 -1.63
Net Profit 20.19 34.96 51.36 95.99 40.47
Adjusted EPS (Rs.) 10.05 17.41 25.57 43.31 18.26

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 8.04 8.04 20.09 22.17 22.17
Total Reserves 71.6 106.41 141.85 446.71 482.62
Borrowings 31.52 38.71 26.76 13.11 4.23
Other N/C liabilities 3.64 4.89 4.06 -8.05 -11.21
Current liabilities 72.57 87.26 127.08 193.55 244.7
Total Liabilities 187.36 245.31 319.83 667.49 742.5
Assets
Net Block 66.71 111.18 120.45 159.61 196.22
Capital WIP 6.04 4.89 9.81 51.49 230.74
Intangible WIP 0 0 0 0 0
Investments 0.67 0.67 0.67 0.67 0.67
Loans & Advances 0.38 0.17 0.3 2.09 2.85
Other N/C Assets 0 0 0 0.51 0.55
Current Assets 113.58 128.4 188.61 453.12 311.47
Total Assets 187.36 245.31 319.83 667.49 742.5
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 26.43 44.22 59.35 103.27 38.83
Adjustment 7.49 8.2 6.92 9.64 15.82
Changes in Assets & Liabilities -20.31 -20.4 -37.55 -75.18 -23.18
Tax Paid -5.74 -7.39 -9.82 -17.97 -7.74
Operating Cash Flow 7.87 24.64 18.91 19.76 23.73
Investing Cash Flow -16.77 -40.18 -20.61 -196.72 -101.13
Financing Cash Flow 17.4 9.7 -4.72 235.01 37.82
Net Cash Flow 8.5 -5.85 -6.42 58.05 -39.59

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 79.17 79.17 72.02 72.02 72.02
ajay mansukhlal patel 18.08 18.08 17.10 17.10 17.10
ajay mansukhlal patel (hu... 4.16 4.16 3.06 3.06 3.06
chintan n shah (huf) 2.02 2.02 1.91 1.91 1.91
chintan nitinkumar shah 22.09 22.09 20.94 20.94 20.94
darshana nitinkumar shah 1.23 1.23 0.17 0.17 0.17
kajalben shekharkumar som... 0.98 0.98 0.93 0.93 0.93
priti ajay patel 4.15 4.15 3.85 3.85 3.85
shekhar rasiklal somani 25.40 25.40 23.07 23.07 23.07
shital chintan shah 1.04 1.04 0.99 0.99 0.99
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 20.83 20.83 27.98 27.98 27.98
goldman sachs funds - gol... - - 1.89 2.06 2.30
icici prudential smallcap... - - 2.19 2.15 2.01
llp 0.02 0.02 0.01 0.09 0.01
mirae asset aggressive hy... - - - 1.64 1.64
nippon life india trustee... - - - 5.93 5.90
sbi magnum midcap fund 2.93 2.93 2.78 2.78 2.77
abu dhabi investment auth... 1.36 1.37 1.23 - -
mirae asset hybrid - equi... 1.73 1.73 1.64 - -
nippon life india trustee... 4.84 5.27 6.21 - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Tatva Chintan Pharma - Quaterly Results3 May 2024, 3:41PM Tatva Chintan Pharma - Quaterly Results3 May 2024, 3:41PM Tatva Chintan Pharma - Quaterly Results3 May 2024, 3:41PM Tatva Chintan Pharma Chem submits analyst meet intimation16 Mar 2024, 11:59AM Tatva Chintan Pharma Chem informs about update27 Jan 2024, 4:28PM Tatva Chintan Pharma - Quaterly Results20 Jan 2024, 3:26PM Tatva Chintan Pharma - Quaterly Results20 Jan 2024, 3:26PM Tatva Chintan Pharma - Quaterly Results20 Jan 2024, 3:26PM Tatva Chintan Pharma Chem informs about earnings call17 Jan 2024, 4:55PM Tatva Chintan Pharma - Quaterly Results2 Nov 2023, 3:57PM Tatva Chintan Pharma - Quaterly Results2 Nov 2023, 3:57PM Tatva Chintan Pharma - Quaterly Results2 Nov 2023, 3:57PM Tatva Chintan Pharma Chem informs about disclosure8 Sep 2023, 3:52PM Tatva Chintan Pharma Chem informs about disclosure7 Sep 2023, 5:16PM Tatva Chintan Pharma Chem informs about newspaper publication5 Aug 2023, 1:27PM Tatva Chintan Pharma - Quaterly Results4 Aug 2023, 3:03PM Tatva Chintan Pharma - Quaterly Results4 Aug 2023, 3:03PM Tatva Chintan Pharma - Quaterly Results4 Aug 2023, 3:03PM Tatva Chintan Pharma Chem informs about newspaper publication6 May 2023, 2:36PM Tatva Chintan Pharma Chem informs about press release5 May 2023, 5:07PM Tatva Chintan Pharma Chem board approves dividend5 May 2023, 4:45PM Tatva Chintan Pharma - Quaterly Results5 May 2023, 3:49PM Tatva Chintan Pharma - Quaterly Results5 May 2023, 3:49PM Tatva Chintan Pharma - Quaterly Results5 May 2023, 3:49PM Tatva Chintan Pharma Chem informs about disclosure 4 May 2023, 4:34PM Tatva Chintan Pharma Chem informs about certificate 12 Apr 2023, 4:51PM Tatva Chintan Pharma Chem starts commercial production of new facility at Dahej Manufacturing Plant6 Apr 2023, 2:38PM Tatva Chintan Pharma Chem informs about analyst meet 25 Feb 2023, 11:55AM Tatva Chintan Pharma - Quaterly Results24 Jan 2023, 3:48PM Tatva Chintan Pharma - Quaterly Results24 Jan 2023, 3:48PM Tatva Chintan Pharma - Quaterly Results24 Jan 2023, 3:48PM Tatva Chintan Pharma Chem informs about board meeting 13 Jan 2023, 4:28PM Tatva Chintan Pharma Chem informs about analyst meet 24 Nov 2022, 10:56AM Tatva Chintan Pharma Chem informs about analyst meet 14 Nov 2022, 2:02PM Tatva Chintan Pharma Chem informs about newspaper publication5 Nov 2022, 3:07PM Tatva Chintan Pharma - Quaterly Results4 Nov 2022, 4:15PM Tatva Chintan Pharma - Quaterly Results4 Nov 2022, 4:15PM Tatva Chintan Pharma - Quaterly Results4 Nov 2022, 4:15PM Tatva Chintan Pharma Chem informs about earnings call31 Oct 2022, 5:14PM Tatva Chintan Pharma Chem informs about trading window closure29 Sep 2022, 4:31PM Tatva Chintan Pharma Chem informs about newspaper publication24 Aug 2022, 1:41PM Tatva Chintan Pharma Chem informs about analyst meet28 Jul 2022, 3:25PM Tatva Chintan Pharma - Quaterly Results25 Jul 2022, 3:44PM Tatva Chintan Pharma - Quaterly Results25 Jul 2022, 3:44PM Tatva Chintan Pharma - Quaterly Results25 Jul 2022, 3:44PM Tatva Chintan Pharma Chem informs about trading window closure29 Jun 2022, 4:44PM Tatva Chintan Pharma Chem informs about analyst meet27 Jun 2022, 11:36AM Tatva Chintan Pharma - Quaterly Results25 Apr 2022, 3:43PM Tatva Chintan Pharma - Quaterly Results25 Apr 2022, 3:43PM Tatva Chintan Pharma - Quaterly Results25 Apr 2022, 3:43PM

Tatva Chintan Pharma Stock Price Analysis and Quick Research Report. Is Tatva Chintan Pharma an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Tatva Chintan Pharma has a PE ratio of 96.8308876862132 which is high and comparatively overvalued .

  • Share Price: - The current share price of Tatva Chintan Pharma is Rs 1214.85. One can use valuation calculators of ticker to know if Tatva Chintan Pharma share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Tatva Chintan Pharma has ROA of 5.73975294877769 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Tatva Chintan Pharma has a Current ratio of 1.2728524724152 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Tatva Chintan Pharma has a ROE of 8.3119364049052 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Tatva Chintan Pharma has a D/E ratio of 0.3373 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Tatva Chintan Pharma has an Inventory turnover ratio of 2.5893385191569 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Tatva Chintan Pharma has reported revenue growth of -5.78923870587712 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Tatva Chintan Pharma for the current financial year is 13.6005001935273 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Tatva Chintan Pharma is Rs 2 and the yield is 0.1647 %.

Last Updated on:
Brief about Tatva Chintan Pharma

Tatva Chintan Pharma Chem Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Tatva Chintan Pharma Chem Ltd., established in 1996, is a specialty chemical manufacturing company based in India. With a focus on manufacturing a wide range of chemical products, the company has built a strong reputation for delivering high-quality products to its customers across various industries. Tatva Chintan Pharma Chem is known for its commitment to research and innovation, continuously developing new products to cater to the evolving market demands.

Tatva Chintan Pharma Chem Ltd. - Share Price

Stay updated with the latest share price of Tatva Chintan Pharma Chem Ltd. on our website. As a long-term stock investor, it is crucial to keep track of the company's share price trends. By analyzing historic share price movements and understanding the factors influencing them, you can make informed decisions regarding your investment portfolio.

Tatva Chintan Pharma Chem Ltd. - Balance Sheet

Access the balance sheet of Tatva Chintan Pharma Chem Ltd. on our website. The balance sheet provides a snapshot of the company's financial position, including its assets, liabilities, and shareholders' equity. With the help of our pre-built screening tools, you can perform a comprehensive analysis to gain insights into the company's financial stability and evaluate its long-term investment potential.

Tatva Chintan Pharma Chem Ltd. - Annual Report

Download the annual reports of Tatva Chintan Pharma Chem Ltd. from our website. The annual report offers detailed information on the company's operations, financial performance, and future prospects. Gain valuable insights into the company's strategies, goals, and achievements, enabling you to assess its growth trajectory and make informed investment decisions.

Tatva Chintan Pharma Chem Ltd. - Dividend

Explore Tatva Chintan Pharma Chem Ltd.'s dividend history on our website. Dividends are a crucial aspect for long-term stock investors seeking stable returns. By analyzing the company's dividend track record, you can evaluate its commitment to distributing profits to its shareholders and make informed decisions regarding dividend-related investment strategies.

Tatva Chintan Pharma Chem Ltd. - Quarterly Result

Stay updated with the latest quarterly results of Tatva Chintan Pharma Chem Ltd. on our website. Monitoring the company's quarterly performance can provide valuable insights into its financial health, growth trajectory, and potential risks. Utilize our pre-built screening tools to conduct in-depth analysis and evaluate the company's strengths and weaknesses.

Tatva Chintan Pharma Chem Ltd. - Stock Price

Monitor the stock price movements of Tatva Chintan Pharma Chem Ltd. on our website. The stock price reflects the market's perception of the company's value and future prospects. Analyzing historical stock price trends can help you identify patterns and make informed decisions regarding buying or selling shares in Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd. - Price Chart

Visualize and analyze the price chart of Tatva Chintan Pharma Chem Ltd. on our website. By studying the price chart, you can identify trends, patterns, and price levels that can assist in making informed investment decisions. Utilize our pre-built screening tools to perform technical analysis and uncover potential trading opportunities.

Tatva Chintan Pharma Chem Ltd. - News

Stay updated with the latest news about Tatva Chintan Pharma Chem Ltd. on our website. Timely information on company announcements, new product launches, collaborations, and industry developments can significantly impact the stock's price and long-term investment prospects. With our comprehensive news coverage, investors can stay ahead and make informed decisions.

Tatva Chintan Pharma Chem Ltd. - Concall Transcripts

Access the concall transcripts of Tatva Chintan Pharma Chem Ltd. on our website. Concall transcripts provide valuable insights into the company's management discussions, strategic decisions, and outlook for the future. By analyzing these transcripts, investors can gain a deeper understanding of the company's operations and make informed investment decisions.

Tatva Chintan Pharma Chem Ltd. - Investor Presentations

Download the investor presentations of Tatva Chintan Pharma Chem Ltd. from our website. Investor presentations offer detailed information about the company's business model, financial performance, growth strategies, and future prospects. By analyzing these presentations, you can assess the company's potential and make informed investment decisions.

Tatva Chintan Pharma Chem Ltd. - Promoters

Learn about the promoters of Tatva Chintan Pharma Chem Ltd. Promoters play a vital role in shaping a company's vision, strategy, and long-term growth plans. Understanding the background, expertise, and track record of the company's promoters can help investors assess the company's stability, governance, and growth potential.

Tatva Chintan Pharma Chem Ltd. - Shareholders

Stay informed about the major shareholders of Tatva Chintan Pharma Chem Ltd. Shareholder analysis provides insights into the ownership structure of the company and the percentage of shares held by institutional investors, mutual funds, and individual investors. This information can aid in evaluating the company's investor confidence and long-term growth potential.

Remember, on our website, along with the above-mentioned stock analysis, we provide pre-built screening tools, downloadable annual reports, concall transcripts, investor presentations, and premium features such as fair value calculations using DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools and resources aim to empower long-term stock investors in making sound investment decisions based on comprehensive analysis and research.

Read More
X